RWE Virtual Symposium

RWE Virtual Symposium

Friday 9 October 2020

Real world evidence: basic roots

• Methodological aspects of RWE
  Fabio Pellegrini
• Registries in RWE generation
  Per-Soelberg Sörensen
• PROMS
  Giancarlo Comi
• LATAM aspects of RWE generation
  Juan Ignacio Rojas
• Discussion Q&A

Real world evidence in MS I: natural history and special conditions

• RWE to assess the natural history of relapsing MS
  Oscar Fernandez
  
• RWE to assess the natural history of progressive MS
  Liliana Patrucco
• RWE and fatigue
  Letizia Leocani
• RWE and cognition in MS
  Maria Pia Amato
• Discussion Q&A

Saturday 10 October 2020

Real world evidence in MS II: assessment of treatment

• RWE effectiveness and safety of injectables
  Jacqueline Palace
• RWE effectiveness and safety of orals
  Liliana Patrucco
• RWE effectiveness and safety of monoclonal antibodies
  Giancarlo Comi
• RWE in pediatric MS
  Maria Pia Amato
• Discussion Q&A

State of the art in NMOSD

• Epidemiology of NMOSD and clinical aspects
  Jacqueline Palace
• Differential diagnosis and the role of functional studies in NMOSD, MOG and MS disease
  Letizia Leocani
• NMOSD and MOG disease in Latin America
  Juan Ignacio Rojas
• Discussion Q&A

Health policies and decisions based on RWE

• RWE in costs data generation in MS
  Juan Pablo Denamiel, Superintendencia de Servicios de Salud Argentina
• Health policies and unmet needs of RWE to make decisions in LATAM
  Fernando Rubinstein, IECS, Argentina
• Multiple Sclerosis care units and research priorities in RWE generation
  Per-Soelberg Sörensen
• Consensus guidelines in helath care policies and decision: round table
  Edgardo Cristiano, Fernando Rubinstein, Juan Pablo Denamiel
• Concluding remarks of the meeting
  Giancarlo Comi, Edgardo Cristiano

For more detailed information and to register, visit the symposium website.